Article: Rosetta Biosoftware Announces the Rosetta Syllego System Version 2.0.

New System Places Translational Medicine Within Researchers' Grasp

SEATTLE -- Rosetta Biosoftware, a global leader in life science informatics solutions, today announced that the Rosetta Syllego[TM] system version 2.0, its system for genetic studies, is now available. The newest version has been designed to create even more opportunities for researchers to see their work impact patient care.

Genetic studies combining microarray technologies, sequencing, and clinical information are poised to impact the way drugs are developed, medicine is practiced, and how patients are cared for. However, researchers still routinely encounter fundamental obstacles and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!